ELLINGTON MANAGEMENT GROUP LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 192 filers reported holding HAEMONETICS CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2018$388,000
+48.7%
5,300
+17.8%
0.03%
-34.9%
Q4 2017$261,000
-29.8%
4,500
-45.8%
0.04%
-32.8%
Q3 2017$372,000
+41.4%
8,300
+25.8%
0.06%
+28.0%
Q3 2013$263,000
-47.4%
6,600
-45.5%
0.05%
-47.4%
Q2 2013$500,00012,1000.10%
Other shareholders
HAEMONETICS CORP shareholders Q3 2013
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders